ARTICLES BY THIS AUTHOR
- 1/9/2020
FlavoRx adds 2 corporate vice presidents
FlavoRx has hired two industry veterans in the wake of growth from its Fillmaster Auto dispensing technology. - 1/8/2020
Pharmacists continue to top annual Gallup Poll as trustworthy professionals
On the heels of Gallup's finding that pharmacists are highly valued, NACDS urges fair reimbursement and better access to pharmacy care. - 1/8/2020
NACDS to HHS inspector general: Pharmacies are essential to value-based care
In comments to the Department of Health and Human Services, NACDS said that pharmacies should be included in the definition of value-based enterprise. - 1/7/2020
Schnucks kicks off community-wide step challenge
Schnucks customers who log 50,000 steps or more now through Feb. 29 have a chance to win $100. - 1/7/2020
Alembic launches generic Temovate
Alembic's generic Temovate provides a short-term topical treatment of inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp. - 1/7/2020
Daiichi Sankyo debuts Enhertu
Enhertu is indicated for the treatment of patients with unresectable or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens. - 1/7/2020
Biosimilar drug approvals soared in 2019
Ten biosimilars were approved in 2019, bringing the number of approved biosimilars to 26 since 2015. - 1/7/2020
FDA report highlights 2019 drug approvals
Twenty-nine of the 48 novel drug approvals of 2019, or 60%, were designated in one or more expedited categories of Fast Track, Breakthrough, Priority Review, and/or Accelerated Approval. - 1/6/2020
Lannett launches 2 generics
Venlafaxine ER tablets, 150 mg and 225 mg, and lidocaine topical solution 4% had a market value of roughly $150 million and $17 million, respectively, for the 12 months ended November 2019. - 1/6/2020
Allergan reaches $300M settlement in Loestrin, Minastrin suit
Warner Chilcott and Watson subsidiaries will pay approximately $300 million under settlement agreements.